21, Oct 2026
IIM Udaipur Launches India’s First One-Year Full-Time MBA in Investment and Wealth Management
The pioneering Program expands IIM Udaipur’s specialised MBA portfolio to address the evolving needs of the investment and wealth management industry.
UDAIPUR, India, Oct. 21, 2026 /PRNewswire/ — The Indian Institute of Management Udaipur (IIM Udaipur) today launched its One-Year MBA in Investment and Wealth Management (IWM), becoming the first and only IIM to offer a dedicated One-Year Full-Time Residential MBA Program in this domain. This pioneering initiative reflects the Institute’s commitment to developing specialised management education that responds to emerging industry needs and evolving career opportunities in the financial services sector.
The Program comes at a time when India’s financial services sector is experiencing significant growth and transformation. Changing investor expectations, evolving financial markets, technological advancements, and increasingly sophisticated financial products are creating a growing need for professionals with specialised knowledge and managerial capabilities in investment and wealth management.
The new MBA Program aims to address this need by offering a focused management education pathway for professionals seeking to develop their expertise in this evolving domain. It further strengthens IIM Udaipur’s commitment to aligning its academic offerings with emerging industry requirements and the changing demands of the professional landscape.
A key distinguishing feature of the Program is its co-creation with leading investment and wealth management firms in India, including 360 ONE, ASK Private Wealth, Client Associates, IIFL Wealth, InCred Wealth, JM Financial, LGT Wealth India, Nippon India AMC, and Nuvame Wealth. These industry partners contribute to curriculum development and review, deliver guest lectures and workshops, and host participants for a one-month industry immersion. This close collaboration between academia and industry helps align the learning experience with contemporary industry practices and professional requirements. By combining IIM Udaipur’s academic rigour with the practical expertise of industry practitioners, the Program aims to equip participants with specialised investment knowledge, wealth advisory capabilities, ethical judgement, and an understanding of client needs—competencies essential for building trusted client relationships and navigating the evolving financial services landscape.
Prof. Rajesh Agrawal, Chairperson, One-Year MBA Programs, IIM Udaipur, said:
“India’s growing financial wealth and increasingly complex investment landscape call for professionals who combine technical expertise with sound judgement and a deep understanding of client needs. Our One-Year MBA in Investment and Wealth Management has been designed to address this need through a distinctive combination of academic rigour and industry expertise. Co-created with leading investment and wealth management firms, the Program emphasises trust, ethics, and fiduciary responsibility while preparing experienced professionals for careers in asset management, private banking, wealth advisory, and family offices. We look forward to developing thoughtful investment professionals, trusted advisors, and responsible leaders for the evolving financial services industry.”
With this launch, IIM Udaipur further expands its portfolio of specialised One-Year MBA programs, complementing its existing offerings in Digital Enterprise Management and Global Supply Chain Management. The addition of Investment and Wealth Management reflects the Institute’s approach to developing management education in response to emerging business needs and specialised professional domains.
The Program also underscores the growing importance of specialised management education in preparing professionals to engage with the opportunities and challenges of an increasingly complex financial ecosystem.
For more information about the Program, visit https://iwm.iimu.ac.in.
About IIM Udaipur
IIM Udaipur is well on its way to becoming a globally recognised B-School. It has broken new ground by focusing on world-class research and transforming students into tomorrow’s managers and leaders. The Institute arrived on the global education stage by securing AACSB (Association to Advance Collegiate Schools of Business) accreditation in just eight years after its establishment. IIMU has been listed on the Financial Times (FT) Global MIM Ranking 2026 for the 8th consecutive year, making it the only IIM to have achieved this feat. In the QS Global MIM Ranking 2027, IIM Udaipur continues to maintain its listing for the 8th year in a row, reinforcing its global standing. Additionally, IIM Udaipur ranks 4th in India for research in management, according to the UT Dallas methodology, which tracks publications in leading global journals, showcasing its excellence in academic research.
View original content to download multimedia:https://www.prnewswire.com/in/news-releases/iim-udaipur-launches-indias-first-one-year-full-time-mba-in-investment-and-wealth-management-302915431.html
- 0
- By PRNewswire
21, Oct 2026
India-US Trade Deal Nears Finalisation as Trump Signals Key Changes in Bilateral Pact
New Delhi/Washington, Oct 21: India and the United States are reportedly moving closer to finalising a bilateral trade agreement, with US President Donald Trump indicating that the proposed pact will feature significant differences from earlier trade arrangements. According to recent statements attributed to senior officials from both countries, negotiations have entered their final stages, although some details remain unresolved.
Representational Image
The development signals continued efforts by New Delhi and Washington to strengthen economic ties, address tariff-related concerns and expand commercial cooperation between the two major economies.
Trump Signals Changes in Proposed Trade Agreement
President Trump has expressed optimism about the progress of negotiations, suggesting that the emerging agreement will have a distinct structure compared with previous bilateral trade arrangements. The discussions follow more than a year of negotiations aimed at resolving differences over tariffs, market access and trade-related policies.
However, the complete terms of the proposed agreement have not yet been officially disclosed. The precise nature of the changes highlighted by Trump, along with the outstanding issues, remains unclear.
Marco Rubio Highlights Progress During India Visit
US Secretary of State Marco Rubio has also indicated that the two countries are approaching an agreement, with only a limited number of issues reportedly awaiting resolution.
His engagement with Indian officials in New Delhi forms part of broader diplomatic efforts to deepen cooperation in areas including energy, technology, defence and trade. These discussions reflect the growing importance both governments attach to their strategic and economic partnership.
Tariffs and Market Access Remain Key Issues
Trade negotiations between India and the United States have faced longstanding challenges involving import duties, access to domestic markets and regulatory differences.
The two governments established an initial framework for the first phase of a trade agreement in February, but subsequent changes in US tariff policy reportedly prompted further discussions.
Indian Commerce and Industry Minister Piyush Goyal has been involved in negotiations with US officials, including US Trade Representative Jamieson Greer, as both sides work to address outstanding commercial and regulatory concerns.
Officials Express Confidence in Final Outcome
US Ambassador to India Sergio Gor has reportedly indicated that major elements of the proposed agreement have been completed. India’s External Affairs Minister S Jaishankar has also expressed confidence in the ongoing diplomatic engagement.
Despite the positive signals, neither the complete text of the agreement nor a confirmed signing date has been announced in the information available for this report. The final outcome will depend on resolving the remaining issues and securing formal approval from both governments.
What the Deal Could Mean for India and the US
A successful agreement could provide greater clarity for businesses operating across both markets, potentially improve trade opportunities and support investment in key sectors. It could also help reduce uncertainty surrounding tariffs and strengthen economic cooperation between the two countries.
For India, the negotiations are important for expanding export opportunities while protecting domestic economic interests. For the United States, a deal could support efforts to improve market access and address trade imbalances.
For now, the positive statements from leaders and senior officials suggest that negotiations are approaching a critical stage. However, the agreement should not be considered final until both governments confirm its terms and announce its formal conclusion.
The bottom line: India and the United States appear to be making progress towards a revised trade agreement, but the final provisions, outstanding issues and signing timeline remain subject to official confirmation.
21, Oct 2026
ESTEVE CDMO expands its presence in Asia with a major investment and new manufacturing site in China
- After more than two decades in China, ESTEVE CDMO marks a new chapter in its commitment to the country and the region.
- With more than $80 million invested, the new facility brings a new generation of manufacturing capabilities, with 250 m³ of reaction volume and potential capacity of more than 400+ m³.
- Advanced manufacturing, automation, and digitalization enhance ESTEVE CDMO’s capabilities and support its continued growth in Asia.
SHAOXING, China, Oct. 21, 2026 /PRNewswire/ — ESTEVE CDMO, Esteve Healthcare contract development and manufacturing organization, is strengthening its presence in Asia through the relocation, expansion and modernization of its existing manufacturing operations in China, supported by an investment of more than $80 million.
The new facility in Shaoxing represents a significant step forward in ESTEVE CDMO’s manufacturing capabilities in China, combining increased capacity with advanced technologies and a high degree of automation and digitalization. Designed with flexibility and future development in mind, the facility will enhance the company’s ability to respond to evolving customer and market needs in China and across the wider Asian market.
“After more than 20 years in China, this investment marks an important new chapter for us in the country. The relocation and expansion of our operations bring together advanced technologies, digitalization, and deep local expertise, strengthening our ability to support customers across China and Asia while further integrating the site into ESTEVE’s global manufacturing network. But what truly differentiates us is the exceptional team that has built this business over the years. Their deep expertise, long-standing commitment, and strong culture are at the heart of what we do and will continue to drive our growth in China and beyond. Ultimately, this is what drives us: making a difference for patients and contributing to our shared purpose of improving lives together.” said Sun Xuejie, Managing Director China & Mexico at ESTEVE CDMO.
Increased capacity and advanced capabilities
The new site comprises three manufacturing workshops with a total reaction volume of 250 m³, with space reserved for an additional 150+ m³, enabling potential total reaction capacity to exceed 400+ m³ as manufacturing needs evolve. The site has been designed with the necessary service and utility infrastructure to support future expansion.
Advanced manufacturing, automation, and digitalization are integrated throughout the facility to enhance operational efficiency, flexibility, and scalability. A purpose-built centralized control center supports the site’s operations, alongside warehousing facilities, an office building and dedicated infrastructure designed to enable future development.
As part of ESTEVE CDMO’s global technology platform, our China operations complement the capabilities available across our broader manufacturing network. Through this integrated footprint, ESTEVE CDMO offers technologies such as Spray Drying and HPAPI manufacturing, supporting the increasingly complex requirements of small-molecule API development and manufacturing.
The project also strengthens local capabilities and supports the development of people and expertise in China, while environmental, health and safety considerations are integrated into the design and operation of the facility. The new site has achieved a “Very Good” BREEAM rating, recognizing its sustainability performance and approach to responsible design and operation. The project has also been selected as a candidate for the BREEAM China Awards. These efforts are part of ESTEVE’s broader commitment to creating positive impact, reinforced by its B Corp Certification and its focus on high standards of social and environmental performance, transparency, and responsible business practices.
More than 20 years in China: strengthening ESTEVE CDMO’s presence in the region
The investment builds on more than two decades of manufacturing experience in China, as well as strong local capabilities and long-term relationships. It reinforces ESTEVE’s commitment to the country and strengthens its platform to support customers across China and the wider Asian market, while further contributing to the company’s global manufacturing network and capabilities.
“ESTEVE’s more than two decades in China are a strong example of the value of long-term commitment and collaboration. This investment reflects the company’s continued confidence in the region and its commitment to strengthening industrial capabilities and creating value locally,” said Francisco de Asís Benítez Salas, Consul General of Spain in Shanghai.
China is an important part of ESTEVE’s global manufacturing network and a key location for serving customers across Asia. The strengthened operations in Shaoxing will enhance local manufacturing capabilities, increase flexibility and provide greater capacity to support customers and partners in China and across the wider Asian market.
The investment also contributes to strengthening local industrial capabilities and developing the people and expertise that support ESTEVE CDMO’s long-term presence in China. At the same time, the operations connect local capabilities with the standards, technology, and know-how of ESTEVE’s global organization.
Supporting ESTEVE’s long-term growth
ESTEVE operates through two strategic businesses, Pharma and CDMO, united by its shared purpose of Improving lives together.
The continued development of ESTEVE CDMO’s manufacturing platform strengthens its capabilities and international reach, while supporting the long-term needs of pharmaceutical partners.
The investment in China brings together more than two decades of local experience with the scale and capabilities of ESTEVE’s global CDMO platform. It provides a stronger foundation for the company’s continued development in China, while reinforcing its ability to support pharmaceutical customers across Asia and contribute to the development of advanced manufacturing capabilities in the region.
About ESTEVE CDMO
ESTEVE CDMO, part of Esteve Healthcare, is a global pure-play partner specialized in small-molecule active pharmaceutical ingredients (APIs) and pharmaceutical intermediates, supporting pharmaceutical and biotech innovators in advancing complex molecules from early development to commercial supply. With over 60 years of experience in development and manufacturing, we combine deep scientific expertise, robust regulatory and quality systems, and a collaborative mindset.
ESTEVE CDMO, with headquarters in Barcelona, has a global network of six development and manufacturing sites across Spain, the United States, Mexico, and China, enabling scalable, resilient, and reliable supply solutions, tailored to each program’s evolving needs.
About ESTEVE
ESTEVE is an international healthcare organization with a clear purpose: improving lives. This reason for reflecting its commitment to patients, healthcare professionals, communities, and innovators; believing that progress in science and health requires collaboration, shared responsibility, and trust. The company upholds strong ESG (Environment, Social & Governance) standards and is certified as a B Corp.
ESTEVE is focused on serving people living with complex diseases with highly specialized solutions. In parallel, under the ESTEVE CDMO scope, the organization works alongside innovators to accelerate treatments through the development and manufacturing of small-molecule APIs.
Founded in 1929 and headquartered in Barcelona, ESTEVE has grown globally, with pharmaceutical affiliates in Europe and the United States; and CDMO facilities in Spain, Mexico, China and the United States.
More information at www.esteve.com.
Press contact: Gemma Mestre, Global External Communications Manager, gmestre@esteve.com
View original content to download multimedia:https://www.prnewswire.co.uk/news-releases/esteve-cdmo-expands-its-presence-in-asia-with-a-major-investment-and-new-manufacturing-site-in-china-302915336.html
21, Oct 2026
HelpMeSee Guwahati Training Operation Reaches 51 Ophthalmologists Across Northeast India
Successful collaboration with HMS Vision Private Limited and Sri Sankaradeva Nethralaya expands access to simulation-based cataract surgical training across four Northeast states
GUWAHATI, India, Oct. 21, 2026 /PRNewswire/ — HelpMeSee and HMS Vision Private Limited, in collaboration with Sri Sankaradeva Nethralaya (SSDN), announced the successful completion of a four-and-a-half-month simulation-based cataract surgical training operation in Guwahati that provided 51 ophthalmologists with access to surgical skills training closer to where they live and work.
Conducted from April through August 2026, the initiative brought two HelpMeSee Eye Surgery Simulators from HMS Private Limited in Mumbai to SSDN in Guwahati, approximately 2,700 kilometers away. The operation provided ophthalmologists from Assam, Arunachal Pradesh, Manipur and Tripura with local access to the HelpMeSee Simulation-based Training Program.
The results exceeded the initiative’s original goal of training 30 cataract surgeons in Manual Small Incision Cataract Surgery (MSICS). In total, 51 ophthalmologists participated, including 26 from SSDN and 25 from other institutions across Northeast India.
“This operation demonstrates what can happen when we bring training closer to ophthalmologists rather than asking them to travel thousands of kilometers to access it,” said Dr. Akshay Nair, Senior Consultant – Market Development Advisor, HMS Vision Private Limited. “By working with Sri Sankaradeva Nethralaya, we expanded access to HelpMeSee simulation-based training and helped ophthalmologists develop surgical skills that can ultimately benefit patients and communities across Northeast India.”
HMS Vision Private Limited, the Indian subsidiary of HelpMeSee, managed the operation and delivered the HelpMeSee Simulation-based Training Program with support from SSDN. An HMS Vision Private Limited Instructor Assistant provided on-site support in Guwahati, while an Instructor in Mumbai remotely observed training sessions, combining local hands-on simulation with continued instructional oversight.
The cohort included 31 residents and 20 fellows. Early follow-up also shows participants progressing in their surgical journeys. Twelve participants had progressed to performing independent surgery, while another 17 had begun assisting with surgical steps. HMS Vision Private Limited continues to follow participants to better understand how their simulation-based training translates into clinical practice over time.
“The four-month HelpMeSee Simulation-based Training Program at Sri Sankaradeva Nethralaya has been a highly valuable experience for both our internal trainees and ophthalmologists from different parts of the North-Eastern region. We have received very encouraging feedback from the participants, particularly on the opportunity to practice and refine their surgical skills in a structured simulation environment and gain greater confidence in their clinical practice,” said Dr. Kasturi Bhattacharjee, Director, Clinical and Academics, Sri Sankaradeva Nethralaya.
The Guwahati operation demonstrates a flexible model for bringing simulation-based surgical education closer to where it is needed. Rather than creating a permanent training center, HelpMeSee training capability was deployed temporarily within SSDN’s established ophthalmic training environment, reducing the need for participants to travel to distant metropolitan training centers.
For HelpMeSee, the success in Guwahati represents more than the completion of one training operation. It demonstrates how partnerships, simulation technology, and a flexible training model can expand access to surgical skill development in regions where geography has traditionally been a barrier.
As HelpMeSee continues to expand simulation-based training across India and globally, the goal remains the same: equip more cataract specialists with the surgical readiness to restore sight in their communities.
About HelpMeSee
In a world where 100 million people are blind or visually impaired due to cataract, HelpMeSee, a not-for-profit under IRS 501(c)(3), has a global mission to eradicate cataract blindness by increasing the training of Manual Small Incision Cataract Surgery (MSICS). This safe and relatively quick procedure delivers successful outcomes at a low cost. The HelpMeSee MSICS training system features high-fidelity, virtual reality simulation with haptic feedback, sophisticated courseware, learning management systems, and electronic learning aids.
HelpMeSee was founded by Al and Jim Ueltschi, who imagined building the MSICS training system by incorporating many of the methods and techniques used successfully in commercial pilot training. As co-founder of Orbis International and founder of FlightSafety International, Al Ueltschi was an icon in the aviation industry and was devoted to ending preventable blindness in the developing world. HelpMeSee trains high quality, very low-cost MSICS to ensure that all communities have access to sight restoring affordable treatment. With more than 40 simulators and 19 training centers worldwide, HelpMeSee partners with governments, universities and innovators to fight the global cataract blindness crisis. For more information, visit http://www.helpmesee.org.
About HMS Vision Private Limited
HMS Vision Private Limited, the Indian subsidiary of HelpMeSee, supports the delivery of simulation-based cataract surgery training programs across India. The organization operates a Training Center of Excellence in Mumbai and collaborates with leading institutions including L. V. Prasad Eye Institute, Aravind Eye Hospital, Sankara Eye Hospital, and Sankara Nethralaya to expand access to high-quality surgical education and strengthen the ophthalmic workforce.
About Sri Sankaradeva Nethralaya
Sri Sankaradeva Nethralaya (SSDN) is a premier not-for-profit tertiary eye care institution based in Guwahati, Assam, and a leading centre of excellence in Northeast India. Established in 1994 under the Sri Kanchi Sankara Health and Educational Foundation, the institution was dedicated to the nation by former Prime Minister Late P. V. Narasimha Rao and later recognized as a “Centre of Excellence” in 2004 by former Prime Minister Dr. Manmohan Singh. Since its inception, SSDN has grown from modest beginnings into a comprehensive, multi-specialty eye care institution addressing the region’s critical need for accessible ophthalmic services.
Amanda Kronberg, Director of Marketing: 720-220-9882
View original content to download multimedia:https://www.prnewswire.com/in/news-releases/helpmesee-guwahati-training-operation-reaches-51-ophthalmologists-across-northeast-india-302914771.html
21, Oct 2026
Mapmygenome Completes Acquisition of dnaPower Inc. to Accelerate North American Expansion in DNA, Microbiome, Longevity and Precision Health Testing
VANCOUVER, BC, Oct. 21, 2026 /PRNewswire/ — Mapmygenome announced the completion of its acquisition of Vancouver-based dnaPower Inc., a pioneer in personal genomics. The strategic transaction expands Mapmygenome’s North American footprint and establishes a market-leading platform in DNA testing, gut microbiome health, longevity, and AI-driven multi-omics testing.
By uniting dnaPower with Mapmygenome’s global scale and premier CAP-accredited clinical laboratory capabilities, including Vancouver-based Microbiome Insights, acquired in 2025, the acquisition creates a centralized platform for DNA, microbiome, pharmacogenetic, and longevity testing dedicated to proactive, preventive healthcare across Canada and the US.
“Acquiring dnaPower is a pivotal step in scaling our North American operations,” said Anu Acharya, Founder and CEO of Mapmygenome. “Pairing dnaPower’s commercial trajectory with our CAP-accredited clinical laboratories and AI capabilities positions us to define the next frontier in microbiome, longevity, and precision health testing.”
“Joining Mapmygenome unlocks an extraordinary growth chapter for dnaPower,” said Dr. Lois Nahirney, Founder and CEO of dnaPower. “Backing from a global leader with elite laboratory infrastructure gives us the foundation to scale rapidly across North America, delivering advanced, high-quality products directly to our clients.”
Strategic Highlights
- Market Expansion: Integrates dnaPower’s consumer reach with Mapmygenome’s global footprint, technology stack, and R&D pipeline.
- Integrated Longevity Engine: Combines multi-omics analytics and clinical laboratory capabilities to deploy new commercial offerings in healthy aging, gut profiling, and epigenetic assessment.
- Centralized Operations: Establishes a Vancouver processing hub operating under CAP-accredited and ISO-certified protocols.
Comprehensive Testing Suite
- Longevity and Gut Health: Advanced shotgun metagenomic sequencing, gut microbiome profiling, epigenetic biological age panels, and longevity insights.
- Genomic and Preventive Health: Whole-genome and exome sequencing, pharmacogenetics, DNA wellness panels, methylation testing, and clinical bioinformatics.
About Mapmygenome
Mapmygenome is a global leader in personal genomics, longevity solutions, and precision medicine. Combining AI-driven multi-omics with premier CAP-accredited clinical laboratory infrastructure, Mapmygenome empowers individuals and healthcare providers with actionable insights across whole-genome sequencing, gut health, and healthy aging to transform preventive care worldwide.
Learn more: mapmygenome.ai
About dnaPower
Founded in 2008 and based in Vancouver, dnaPower specializes in actionable DNA-based health, nutrition, fitness, methylation, and longevity insights for consumers and practitioners.
Learn more: dnaPower.com
About Microbiome Insights
Microbiome Insights, a Mapmygenome company, is a Canadian provider of CAP-accredited DNA, microbiome, and multi-omics sequencing, analytics, and bioinformatics services.
Learn more: Microbiomeinsights.com
Media Contact
Email: anu@mapmygenome.ai
View original content to download multimedia:https://www.prnewswire.com/in/news-releases/mapmygenome-completes-acquisition-of-dnapower-inc-to-accelerate-north-american-expansion-in-dna-microbiome-longevity-and-precision-health-testing-302915385.html
21, Oct 2026
Mahindra Manulife Insurance appoints Nilesh Kothari as Chief Financial Officer
Mumbai, October 21, 2026: Mahindra Manulife Insurance Limited (MMIL) has appointed Nilesh Kothari as Chief Financial Officer (CFO), as the company builds its leadership team and prepares to launch a differentiated, future-ready life insurance business in India.
With over 22 years of experience in the life insurance industry, Nilesh brings deep expertise across financial strategy, capital and solvency management, business planning, investment operations, governance and regulatory engagement. Prior to joining Mahindra Manulife, he was CFO at PNB MetLife India Insurance and has previously held CFO and senior leadership roles at Bharti AXA Life and SBI Life Insurance. During his career, he has led initiatives spanning business growth and profitability, operational efficiency and large-scale finance transformation, including ERP and analytics-led modernization programs.
At Mahindra Manulife, Nilesh will focus on building a future-ready finance function that supports the successful launch and sustainable growth of the company. His mandate will include establishing strong financial governance, capital and solvency management and scalable processes.
Commenting on the appointment, Suresh Agarwal, Managing Director & CEO, Mahindra Manulife Insurance, said, “Nilesh brings deep life insurance expertise and a strong combination of financial stewardship, strategic thinking and transformation experience. As we build Mahindra Manulife, establishing strong financial foundations while creating an organization designed for the future will be critical. Nilesh’s experience across financial strategy, capital and solvency management, governance and technology-led transformation will play an important role as we build a sustainable, agile and future-ready life insurance business.”
Sharing his vision for the new role, Nilesh Kothari, Chief Financial Officer, Mahindra Manulife Insurance, said, “I am delighted to join Mahindra Manulife at this exciting stage as we prepare to launch a future-ready life insurance company. By combining the strength of both the trusted brands – Mahindra and Manulife with AI, technology and data-led capabilities, we have a compelling opportunity to reimagine customer experience and build a scalable, agile and sustainable business. I look forward to partnering with the leadership team to create value for customers, shareholders and employees.”
Nilesh was recognized as CFO of the Year in 2022 by the Institute of Chartered Accountants of India (ICAI). He holds a Bachelor of Commerce degree from the University of Mumbai and a Diploma in Information Systems Audit (DISA). He has also completed executive programmes at the Tuck School of Business at Dartmouth and IIM Bangalore.
21, Oct 2026
IIT Madras launches Finishing School to develop industry-ready biotechnology professionals
Chennai, 21st October 2026: Indian Institute of Technology Madras (IIT Madras) has launched an industry-oriented finishing school to equip young graduates with practical skills and professional competencies required by the biotechnology and biomanufacturing sectors.
‘UDYOG’ (Upskilling and Development for YOung Graduates) aims to bridge the gap between academic education and industry requirements through a structured training pathway. It combines online courses, intensive laboratory training, pilot-scale exposure and opportunities for industry internships.
The first batch of the Finishing School is scheduled to commence on 18th January 2027, and the early-bird registration closes on 15th December 2026. Interested students can submit an expression of interest through – https://code.iitm.ac.in/
The initiative is expected to support workforce development and contribute to India’s ambitions to strengthen its bioeconomy through innovation, advanced manufacturing capabilities and specialised skills.
The programme is intended for pre-final-year and final-year students, who are pursuing B.Tech., M.Tech. and M.Sc. degrees in biotechnology and allied disciplines, across all colleges and institutes in India.
Prof. V. Kamakoti, Director, IIT Madras, inaugurated ‘IITM-Biofoundry Finishing School – UDYOG’ at the campus today (21st Oct 2026) in the presence of faculty, students, researchers and industry stakeholders.
It is being launched through SynBioME – the IIT Madras-TICEL Biofoundry, which focuses on advancing biotechnology research, innovation, biomanufacturing and skill development. It is coordinated by Prof. Guhan Jayaraman, Professor, Department of Biotechnology, IIT Madras, who serves as the Principal Coordinator.
Addressing the launch event, Prof. V. Kamakoti, Director, IIT Madras, said, “AI also means Academia-Industry. It is becoming an absolute necessity that every discipline of Science and Engineering must look at this AI with care to make themselves relevant to the modern world. UDYOG is yet another effort taken by IIT Madras in this direction.”
Further, Prof. Guhan Jayaraman, Principal Coordinator, SynBioME and faculty Department of Biotechnology, IIT Madras, added, “India’s biotechnology and biopharmaceutical sectors are expanding at a rapid place. This is leading to a growing demand for professionals with practical expertise in industrial processes, analytical techniques, process development and regulatory practices. UDYOG seeks to address this demand by complementing academic knowledge with industry-relevant training and exposure to real-world biomanufacturing practices.”
Further, Mr. Chella Pandian Pitchai, Biocon – AVP & Global Head DEI | Culture, Values and Belongingness | Youth and Women Development, said, “Best wishes on the launch of the IITM-BioFoundry Finishing School. Science and biotechnology hold immense promise for the future, and empowering young people with the knowledge and confidence to contribute is vital. Preparing them to make a difference takes more than classroom learning; industry exposure through internships and mentorship can help build their readiness to turn knowledge into meaningful impact. I’m excited to see how the next generation of biotechnology talent will drive positive change and take the field to the next level.”
THREE-STAGE TRAINING
The finishing school will follow a three-stage training pathway. The first stage comprises three months of online learning delivered through Centre for Outreach and Digital Education (CODE), IIT Madras, supplemented by lectures from industry experts and demonstration videos illustrating industrial practices.
Participants who successfully complete the online component will be considered for selection to four-week intensive hands-on training program at the IIT Madras Biofoundry. The practical component is designed to provide exposure to laboratory processes and biomanufacturing workflows.
Following the hands-on training, selected participants may have opportunities to engage with industry partners and participate in interviews for long-term internships, providing a potential pathway from academic learning to workplace experience.
21, Oct 2026
KuCoin TradFi Expands 24/7 Trading to Over 170 Assets Referencing Global Equities, Metals and Other Commodities
PROVIDENCIALES, Turks and Caicos Islands, Oct. 21, 2026 /PRNewswire/ — KuCoin, a leading global crypto platform built on trust, today announced an expansion of KuCoin TradFi to offer eligible users access to contracts referencing U.S., Hong Kong and South Korean equities, metals and other commodities. KuCoin TradFi now offers more than 170 perpetual contract pairs across eight categories.
Building on the introduction of Stock Index Perpetual Contracts in March 2026, KuCoin has continued expanding its range of traditional asset-linked derivatives for eligible users. The lineup includes contracts referencing technology and semiconductor companies, such as Tesla, NVIDIA, Micron and SanDisk, alongside index- and ETF-linked contracts and contracts referencing commodities including crude oil, natural gas, copper and silver.
The expanded selection provides exposure to a range of regional markets and market themes, including AI, semiconductors, energy and metals. Subject to applicable product terms and eligibility requirements, users can respond to corporate earnings, technology investment and commodity cycles through long or short positions. Settled in USDT and available for 24/7 trading, the contracts allow users to manage positions and respond to developments beyond traditional exchange hours through a familiar futures interface.
For eligible users at VIP1 and above, KuCoin’s Unified Trading Account (UTA) supports TradFi futures trading within a shared framework for funds, margin and risk management, reducing transfers between separate trading accounts. UTA account holders can also use KCUSD as margin for supported TradFi positions while eligible holdings continue earning rewards under applicable product rules, enabling more flexible capital use without first redeeming or converting KCUSD.
The expansion advances KuCoin 5.0’s vision of bringing trading, asset management and global market opportunities together on one platform. It reinforces the “Trust, Built-in.” initiative through broader asset choice, unified account management, more flexible margin use and transparent trading mechanisms. KuCoin will continue building a more connected platform that gives users greater flexibility, efficiency and control.
Visit the TradFi Futures Spin campaign page to explore KuCoin’s expanded TradFi offering and review the applicable campaign terms and conditions.
About KuCoin
Founded in 2017, KuCoin is a leading global crypto platform built on trust and security, serving over 45 million users across 200+ countries and regions. Known for its reliability and user-first approach, the platform builds trust into every layer of the user experience, combining advanced technology, deep liquidity, and strong security safeguards to deliver a seamless trading experience. KuCoin provides access to 1,000+ digital assets through a broad product suite and remains committed to building a compliant and user-centric ecosystem for the future of finance, backed by SOC 2 Type II, ISO/IEC 27001:2022, ISO/IEC 27701:2019, ISO 22301:2019 and ISO/IEC 42001:2023 certifications. In recent years, KuCoin has continued to strengthen its global compliance foundation, marked by key milestones including AUSTRAC registration in Australia, a MiCA license in Europe, and regulatory progress in other markets.
Learn more at www.kucoin.com.
Disclaimer
This material is for informational purposes only and does not constitute investment advice or an offer or solicitation. Trading digital assets and related products involves significant risks, including the potential loss of invested funds. Product availability is subject to applicable laws, regulations, and eligibility requirements.
View original content to download multimedia:https://www.prnewswire.co.uk/news-releases/kucoin-tradfi-expands-247-trading-to-over-170-assets-referencing-global-equities-metals-and-other-commodities-302915203.html
21, Oct 2026
JEET AI Launches India’s First AI Tutor That Goes Beyond Answers to Actually Teach
NEW DELHI, Oct. 21, 2026 /PRNewswire/ — JEET AI introduces India’s first AI Tutor that truly teaches, replicating the experience of learning with a personal teacher. Rather than waiting for students to ask questions, it actively teaches concepts, writes and annotates on a virtual board, presents relevant multimedia content, and uses interactive simulations to simplify complex topics. For instance, while teaching a concept in Chemistry, JEET AI can illustrate chemical reactions, explain the underlying science through visual demonstrations, and pause to test whether the student has understood the concept before moving forward.
Just like a good teacher, it continuously checks comprehension, asks questions, and tests students throughout the lesson, adapting its explanations based on their understanding. Students can interrupt at any moment, ask unlimited questions, and request explanations repeatedly, without hesitation or judgment. JEET AI has launched with teaching capabilities in Hindi, with support for additional Indian languages, including Tamil and Kannada, set to be introduced in the coming months.
For decades, students have relied on coaching centres, recorded lectures, and YouTube videos to prepare for their examinations. However, teaching hundreds of students simultaneously has made truly personalized learning nearly impossible. While personal tutoring offers individual attention, its high cost makes it inaccessible to most families. AI chatbots have made doubt solving easier than ever but answering questions and actually teaching are two very different things. JEET AI has set out to bridge this gap, bringing personalized teaching to students across India at a starting price of just ₹1,499 per month.
Ritvik Kulshrestha, Founder of Jeet AI and CEO of Extramarks Education, said, “For centuries, the best form of education has been a great teacher sitting beside a student, understanding their difficulties, and adapting to their needs. Unfortunately, this level of personal attention has always been a privilege available to very few. With JEET AI, we are using technology to change that. Our goal is not to build another tool that answers questions, but to make the experience of having a great personal teacher accessible to every student.”
Combining over 15 years of educational expertise, proprietary content, and pedagogical research from Extramarks Education, JEET AI goes beyond conventional AI tools to deliver an immersive, interactive learning experience that replicates a personalized one-on-one learning environment. Whether mastering a concept, learning an entire subject, or preparing for JEE or school examinations, JEET AI delivers structured, interactive, and personalized teaching, followed by targeted practice and comprehensive assessments to identify learning gaps and ensure thorough understanding and mastery of every concept.
Starting at just ₹1,499 per month, JEET AI aims to make personal tutoring affordable at an unprecedented scale. While conventional coaching programmes can cost lakhs of rupees, often without individualized attention, JEET AI brings a dedicated AI teacher within reach of families nationwide. Its ambition is to provide students with a comprehensive alternative to expensive coaching, recorded lectures, and multiple AI learning tools, all through one affordable platform.
Kulshrestha added, “Our vision is simple. No student’s potential should be limited by their family’s income, location, or language. We want every student to have access to a great personal teacher, and we believe AI can finally make that possible.”
JEET AI is initially launching with JEE and Foundation courses in Hindi, followed by the introduction of NEET, CBSE Board preparation, and other courses, along with support for additional Indian languages, over the coming weeks and months.
Brand Film: https://youtu.be/_MGN46IXeGY?si=6ECuQoNmaoNXZ_QK
About JEET AI
JEET AI is an AI-powered personal tutor founded by Ritvik Kulshrestha, Founder of JEET AI and CEO of Extramarks Education. Built on Extramarks’ 15+ years of educational expertise, proprietary content and pedagogical research, it is designed to make structured, personalised learning more accessible to students across India.
For more information, visit https://www.jeetai.live/.
Download JEET AI on Google Play Store:
https://play.google.com/store/apps/details?id=com.jeetai.app&hl=en_IN
View original content to download multimedia:https://www.prnewswire.com/in/news-releases/jeet-ai-launches-indias-first-ai-tutor-that-goes-beyond-answers-to-actually-teach-302915325.html
21, Oct 2026
Kota, Beyond the Expected: Discover a New Place to Stay, Dine and Celebrate
Bengaluru / Kota, 21 October 2026: Think Kota, and education may be the first thing that comes to mind. But look a little further, and there are lakeside views, historic palaces, riverfront experiences and local discoveries waiting to be explored. Adding a new reason to experience the city, Royal Orchid Hotels Ltd. (ROHL), through its subsidiary Regenta Hotels Private Limited, has launched Regenta Place, Kota-a contemporary hospitality destination designed for travellers visiting the city for business, family, leisure or celebrations.
Situated at Aerodrome Circle on DCM Road, the hotel offers a convenient base from which to experience Kota, with thoughtfully equipped accommodation, all-day dining and versatile venues for gatherings of every kind.
Your Kota Stay, Your Way
Whether it is a family trip, a business visit or a few days spent discovering the city, comfort makes all the difference. Regenta Place offers 57 rooms and suites across Executive Rooms, Executive Twin Rooms, Royal Rooms and Suites. High-speed Wi-Fi, Smart TVs, digital safes, tea and coffee makers, in-room dining and 24-hour hot and cold water help make every stay convenient.
Good Food Is Always Part of the Journey
At Pinxx, the hotel’s all-day dining restaurant, guests can explore Indian, Oriental, Continental and regional flavours. From a leisurely breakfast before heading out to a satisfying meal after a day of sightseeing, Pinxx brings a range of dining choices together in one place.
From Grand Celebrations to Meaningful Gatherings
Some trips are remembered for the places visited; others, for the people who came together. Regenta Place caters to both with two indoor venues: Crystal Hall, approximately 8,400 sq. ft., and Sapphire Hall, approximately 2,200 sq. ft. Designed to accommodate gatherings of varying sizes, the venues are suited to weddings, social celebrations, conferences and business events. A fitness centre and ample parking further enhance the guest experience.
The Other Side of Kota Is Waiting
For travellers looking to add discovery to their stay, Kota offers plenty to explore. Take in the playful landmarks at Seven Wonders Park, spend time around Kishore Sagar Lake, discover Jagmandir Palace, experience the Chambal River Front or explore the heritage of Kota Garh and the Rao Madho Singh Museum.
These attractions offer opportunities for sightseeing, photography and cultural exploration-making Kota an interesting stop for visitors who want to look beyond the familiar and experience more of the city.
Chander K. Baljee, CMD, Royal Orchid Hotels Ltd., said: “Kota holds a significant position as one of India’s leading education and coaching hubs, attracting students, families and business travellers throughout the year. With Regenta Place, Kota, we are strengthening our presence in Rajasthan and expanding our reach in an important urban destination.”
Keshav Baljee, Executive Director, Royal Orchid Hotels Ltd., said: “Every destination has more to offer when travellers have the right place to stay. Kota brings together education, business, heritage and family travel, and Regenta Place is designed to serve these varied needs with comfortable accommodation, dining and event facilities. We look forward to being part of the experiences that bring visitors to the city.”
Susheel Jain, Owner of Regenta Place, Kota, said: “Partnering with an established hospitality group gives us an opportunity to combine our understanding of the local market with the Group’s experience in hotel operations and guest service. We look forward to welcoming guests with comfortable accommodation, quality dining and well-equipped event spaces.”
A new stay. More ways to experience Kota. With its mix of contemporary comfort, varied dining and event facilities, Regenta Place invites business travellers, families, celebration planners and city explorers to make their time in Kota more rewarding.
